Dr. Palomares is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
440 E Huntington Dr, Suite 300
Arcadia, CA 91006Phone+1 833-363-2627
Summary
- Dr. Melanie Palomares is an oncologist, epidemiologist, and geneticist in Arcadia, CA and is affiliated with the University of Southern California Keck School of Medicine. She received her medical degree from Emory University School of Medicine and has been in practice 24 years. She also speaks multiple languages, including Spanish. She specializes in cancer genetics and cancer risk assessment and is experienced in risk-based prevention and early detection of breast pathologies, gynecologic neoplasms, and colorectal cancer, as well as general women's health.
Education & Training
University of Washington School of MedicinePost-Doctoral Fellowship, 2002 - 2003
University of Washington School of Public HealthM.S., Epidemiology, 1998 - 2002- University of WashingtonFellowship, Hematology and Medical Oncology, 1997 - 2000
Los Angeles County-Harbor-UCLA Medical Center 1Fellowship, Hematology and Medical Oncology, 1996 - 1997- Los Angeles County-Harbor-UCLA Medical CenterResidency, Internal Medicine, 1993 - 1996
Emory University School of MedicineClass of 1993
Certifications & Licensure
CA State Medical License 1994 - 2021
WA State Medical License 1997 - 2004
Awards, Honors, & Recognition
- Marni Levine Memorial Research Award Stop Cancer Foundation
Clinical Trials
Publications & Presentations
PubMed
- 839 citationsBreast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasisMiranda Y. Fong, Weiying Zhou, Liang Liu, Aileen Y. Alontaga, Manasa Chandra
Nature Cell Biology. 2015-01-26 - 187 citationsRisk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort studyMarlies Kempers, Roland P. Kuiper, Charlotte W. Ockeloen, Pierre O. Chappuis, Pierre Hutter
The Lancet. Oncology. 2011-01-01 - 869 citationsCancer-Secreted miR-105 Destroys Vascular Endothelial Barriers to Promote MetastasisWeiying Zhou, Miranda Y. Fong, Yongfen Min, G. Somlo, Liang Liu
Cancer Cell. 2014-04-14
Professional Memberships
- Member
- Member
Other Languages
- Spanish
Industry Relationships
- Senior Medical Director, CovanceConsulting and monitoring of global oncology clinical trials2015 - 2021
External Links
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
